Colgate-Palmolive (CL): Chief Growth Officer had shares withheld for tax 6,117 shares
John Hazlin, Chief Growth Officer at Colgate-Palmolive, reported a tax withholding of 6,117 shares.
- 6,117
- Shares · @ $97.10
- Traded
- Feb 23, 2026
- Filed
- Feb 25, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 30, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 4, 2026Insider · 3 peopleInsiders: 3 sales (~$15.6M)
- Feb 5, 2026InsiderOfficer sold ~$1.51M of CL shares in the open market
- Feb 6, 2026InsiderOfficer sold ~$1.21M of CL shares in the open market
- Feb 10, 2026InsiderOfficer sold ~$1.98M of CL shares in the open market
- Feb 11, 2026InsiderOfficer sold ~$3.31M of CL shares in the open market
- Feb 12, 2026InsiderOfficer sold ~$1.47M of CL shares in the open market
What came next
- Mar 12, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 12, 2026, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate-Palmolive”) elected Christopher S. Boerner, Ph.D., Board Chair and Chief Executive Officer of Bristol-Myers Squibb Company (“Bristol Myers Squibb”), to the Colgate-Palmolive Board, effective March 15, 2026.”
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Apr 8, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Jennifer M. Daniels, who has served as Chief Legal Officer and Secretary of Colgate-Palmolive Company (the “Company”) since 2014, has communicated to the Company her intention to retire from the Company in 2026.”
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- Apr 30, 2026Company filing · Form 8-K · Results, RestructuringAnnounced job cuts, closures or a restructuring, and reported its results“As previously disclosed, on July 31, 2025, the Company’s Board of Directors (“Board”) approved a three-year productivity program to drive future growth and support the Company’s 2030 strategy (the “Strategic Growth and Productivity Program”).”
- May 7, 2026InsiderOfficer sold ~$752K of CL shares in the open market
- May 15, 2026InsiderOfficer sold ~$203K of CL shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Colgate-Palmolive
For Colgate-Palmolive, OQRO holds 10 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CL page.
Other recent filings by John Hazlin, Chief Growth Officer
The full history of John Hazlin, Chief Growth Officer is on the profile page.
How this filing works
Explore the data
Common questions
Which Colgate-Palmolive (CL) insider traded, and how much?
John Hazlin, Chief Growth Officer at Colgate-Palmolive, reported a tax withholding of 6,117 shares. At $97.10.
When did it happen, and when was it made public?
Traded: Feb 23, 2026. Filed: Feb 25, 2026. That is 2 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Colgate-Palmolive recently?
For Colgate-Palmolive, OQRO holds 10 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the CL page.
Does this mean CL stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Colgate-Palmolive
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 6, 2026
- SEC Form 4Nov 6, 2026
- SEC Form 4Nov 6, 2026
Everything OQRO holds on this company is on its CL page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
